amdinocillin pivoxil has been researched along with zithromax in 1 studies
Studies (amdinocillin pivoxil) | Trials (amdinocillin pivoxil) | Recent Studies (post-2010) (amdinocillin pivoxil) | Studies (zithromax) | Trials (zithromax) | Recent Studies (post-2010) (zithromax) |
---|---|---|---|---|---|
240 | 89 | 46 | 6,964 | 1,263 | 3,790 |
Protein | Taxonomy | amdinocillin pivoxil (IC50) | zithromax (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Broe, A; Brønniche, LMS; Damkier, P; Korch-Frandsen, JFB | 1 |
1 other study(ies) available for amdinocillin pivoxil and zithromax
Article | Year |
---|---|
In utero exposure to antibiotics and risk of congenital malformations: a population-based study.
Topics: Adult; Amdinocillin Pivoxil; Anti-Bacterial Agents; Azithromycin; Case-Control Studies; Cohort Studies; Congenital Abnormalities; Denmark; Educational Status; Employment; Female; Heart Defects, Congenital; Humans; Logistic Models; Maternal Age; Maternal Exposure; Obesity, Maternal; Odds Ratio; Penicillins; Pregnancy; Pregnancy Trimester, First; Smoking; Sulfamethizole; Young Adult | 2019 |